Authors: ROSELL R SACRISTAN JA DUTHIE T CARDENAL F ARTAL A CARRATO A LOMAS M BARNETO I BAMETO I MASSUTI B

Citation: R. Rosell et al., COST-EFFECTIVENESS OF GEMCITABINE (GEMZAR(TM)) PLUS CISPLATIN VERSUS ETOPOSIDE PLUS CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) IN SPAIN, Annals of oncology, 9, 1998, pp. 445-445